Vida Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 09-12-2024
- Paid Up Capital ₹ 2.30 M
as on 09-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 09-12-2024
- Satisfied Charges ₹ 8.50 M
as on 09-12-2024
- Revenue 4.68%
(FY 2023)
- Profit 7.76%
(FY 2023)
- Ebitda 19.87%
(FY 2023)
- Net Worth 4.85%
(FY 2023)
- Total Assets 7.71%
(FY 2023)
About Vida Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.30 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹8.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Madhure, Sheelavathi Annaiyappa, Vijaya Damodaran, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232KA2004PTC033454
- Company No.
033454
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vida Laboratories Private Limited offer?
Vida Laboratories Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Vida Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaya Damodaran  | Whole-Time Director | 10-Oct-2009 | Current |
| Sunil Madhure | Whole-Time Director | 30-Apr-2004 | Current |
| Sheelavathi Annaiyappa | Whole-Time Director | 30-Apr-2004 | Current |
| Sudha Vijayaprabu | Whole-Time Director | 24-Aug-2005 | Current |
Financial Performance of Vida Laboratories.
Vida Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.68% increase. The company also saw a slight improvement in profitability, with a 7.76% increase in profit. The company's net worth moved up by a moderate rise of 4.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vida Laboratories?
In 2023, Vida Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Apr 2022 | ₹1.00 Cr | Open |
State Bank Of Mysore Creation Date: 22 Jun 2007 | ₹6.00 M | Satisfied |
State Bank Of Mysore Creation Date: 21 Feb 2007 | ₹2.50 M | Satisfied |
How Many Employees Work at Vida Laboratories?
Unlock and access historical data on people associated with Vida Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vida Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vida Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
